Shenzhen Wote Advanced Materials Co.Ltd(002886) proposed
Capital increase of Shenzhen Huabao biomaterial Technology Co., Ltd
Shenzhen Huabao biomaterial Technology Co., Ltd
Total equity value of shareholders
assets valuation statement
Zhong Shui Zhi Yuan Ping Bao Zi [2021] No. 010358
(Volume 1 of 1)
Zhongshui Zhiyuan Assets Appraisal Co., Ltd
January 10, 2002
catalogue
Catalog- 2 – statement- 3 – Summary- 5 – text- 7 – I. overview of the client, the appraised entity and the users of other asset appraisal reports agreed in the asset appraisal entrustment contract- 7 – II. Evaluation purpose- 10 – III. appraisal object and scope- 10 – IV. value type- 13 – V. appraisal base date- 13 – VI. evaluation basis- 13 – VII. Evaluation method- 17 – VIII. Application of specific evaluation methods of various assets and liabilities in the asset based method- 18 – IX. implementation process and situation of the evaluation procedure- 18 – X. evaluation assumptions- 21 – Xi. Appraisal conclusion- 23 – XII. Description of special matters- 24 – XIII. Description of restrictions on the use of asset appraisal report- 26 – XIV. Date of assets appraisal report- 27 – attachment of asset appraisal report- 29 –
Zhongshui Zhiyuan Assets Appraisal Co., Ltd. – 2-
statement
1、 The assets appraisal report is prepared in accordance with the basic standards for assets appraisal issued by the Ministry of Finance and the asset appraisal practice standards and professional ethics standards issued by China Assets Appraisal Association.
2、 The client or other users of the asset appraisal report shall use the asset appraisal report in accordance with the provisions of laws, administrative regulations and the scope of use specified in the asset appraisal report; If the client or other users of the asset appraisal report use the asset appraisal report in violation of the above provisions, the asset appraisal institution and its asset appraisal professionals shall not be liable.
3、 The asset appraisal report can only be used by the client, other users of the asset appraisal report agreed in the asset appraisal entrustment contract and users of the asset appraisal report stipulated by laws and administrative regulations; In addition, no other institution or individual can become the user of the asset appraisal report. 4、 The user of the asset appraisal report shall correctly understand and use the appraisal conclusion. The appraisal conclusion is not equal to the realizable price of the appraisal object, and the appraisal conclusion shall not be regarded as a guarantee for the realizable price of the appraisal object.
5、 The asset appraisal institution and its asset appraisal professionals shall abide by laws, administrative regulations and asset appraisal standards, adhere to the principles of independence, objectivity and impartiality, and be responsible for the asset appraisal report issued according to law.
6、 The list of assets and liabilities involved in the appraisal object shall be declared by the client and the appraised unit and confirmed by signature, seal or other methods permitted by law; The client and other relevant parties shall be responsible for the authenticity, integrity and legitimacy of the materials provided by them according to law.
7、 There is no existing or expected interest relationship between the asset appraisal institution and its professionals and the appraisal object in the asset appraisal report; There is no existing or expected interest relationship with the relevant parties, and there is no prejudice against the relevant parties.
8、 We have conducted on-site investigation on the appraisal object and the assets involved in the asset appraisal report; The legal ownership status of the appraisal object and its involved assets has been given necessary
Zhongshui Zhiyuan Assets Appraisal Co., Ltd. – 3-
We have checked the legal ownership information of the appraisal object and the assets involved, truthfully disclosed the problems that have been found, and requested the client and other relevant parties to improve their property rights to meet the requirements of issuing the asset appraisal report.
9、 The analysis, judgment and results in the asset appraisal report issued by the asset appraisal institution are limited by the assumptions and restrictions in the asset appraisal report. The user of the asset appraisal report shall fully consider the assumptions, restrictions and special matters stated in the asset appraisal report and their impact on the appraisal conclusion.
Zhongshui Zhiyuan Assets Appraisal Co., Ltd. – 4-
Shenzhen Wote Advanced Materials Co.Ltd(002886) proposed
Capital increase of Shenzhen Huabao biomaterial Technology Co., Ltd
Shenzhen Huabao biomaterial Technology Co., Ltd
Total equity value of shareholders
assets valuation statement
Zhong Shui Zhi Yuan Ping Bao Zi [2021] No. 010358
abstract
Zhongshui Zhiyuan Assets Appraisal Co., Ltd. accepted the entrustment of Shenzhen Wote Advanced Materials Co.Ltd(002886) to appraise the market value of all shareholders’ rights and interests of Shenzhen Huabao biomaterial Technology Co., Ltd. involved in the capital increase of Shenzhen Wote Advanced Materials Co.Ltd(002886) on the benchmark date of December 31, 2021. The main contents of the assets appraisal report are summarized as follows:
1、 Appraisal purpose: Shenzhen Wote Advanced Materials Co.Ltd(002886) it is proposed to increase the capital of Shenzhen Huabao biomaterial Technology Co., Ltd. and Zhongshui Zhiyuan Asset Appraisal Co., Ltd. accepted the entrustment of Shenzhen Wote Advanced Materials Co.Ltd(002886) to evaluate the market value of all shareholders’ rights and interests of Shenzhen Huabao biomaterial Technology Co., Ltd. involved in the above economic behavior as a value reference for the economic behavior.
2、 Appraisal object and scope: the appraisal object is the value of all shareholders’ equity of Shenzhen Huabao biomaterial Technology Co., Ltd. The appraisal scope covers all assets and liabilities of Shenzhen Huabao biomaterial Technology Co., Ltd. that have not been audited. On the benchmark date of December 31, 2021, the book value of the total assets of the enterprise is 9600 yuan, the book value of the total liabilities is 000 yuan, and the book value of the owner’s equity is 9600 yuan.
3、 Value type: market value.
4、 Benchmark date: December 31, 2021.
5、 Appraisal method: asset based method.
6、 Appraisal conclusion: according to the appraisal, on the benchmark date of December 31, 2021, the value of all shareholders’ equity of Shenzhen Huabao biomaterial Technology Co., Ltd. is RMB 1320200, and the amount in words is RMB one million three hundred and twenty thousand two hundred.
7、 Validity period of the appraisal conclusion: according to relevant regulations, the validity period of the appraisal conclusion in this report is in principle one year from the base date of the appraisal, that is, from December 31, 2021 to December 30, 2022.
8、 Special matters affecting the appraisal conclusion: when using the appraisal conclusion, the users of the appraisal report shall pay attention to the appraisal assumptions and restrictions, the description of special matters and their impact on the appraisal conclusion in the main body of the report, and give full consideration to it when using the report. The above contents are extracted from the text of the asset appraisal report. To understand the details of the appraisal business and correctly understand and use the appraisal conclusion, you should read the text of the asset appraisal report.
Shenzhen Wote Advanced Materials Co.Ltd(002886) proposed
Capital increase of Shenzhen Huabao biomaterial Technology Co., Ltd
Shenzhen Huabao biomaterial Technology Co., Ltd
Total equity value of shareholders
assets valuation statement
Zhong Shui Zhi Yuan Ping Bao Zi [2021] No. 010358
text
Shenzhen Wote Advanced Materials Co.Ltd(002886) ：
Zhongshui Zhiyuan Assets Appraisal Co., Ltd. accepts the entrustment of your company, adheres to the principles of independence, objectivity and impartiality, adopts the asset-based method and follows the necessary appraisal procedures in accordance with the provisions of laws, administrative regulations and asset appraisal standards, The market value of all shareholders’ equity of Shenzhen Huabao biomaterial Technology Co., Ltd. involved in the economic behavior of Shenzhen Wote Advanced Materials Co.Ltd(002886) proposed capital increase of Shenzhen Huabao biomaterial Technology Co., Ltd. on the benchmark date of December 31, 2021 was evaluated.
The asset appraisal report is as follows: I. overview of the client, the appraised unit and other users of the asset appraisal report agreed in the asset appraisal entrustment contract
(I) overview of the client
Company name: Shenzhen Wote Advanced Materials Co.Ltd(002886) (hereinafter referred to as: Shenzhen Wote Advanced Materials Co.Ltd(002886) )
Unified social credit Code: 9144030073416109×8
Address: room 3101, block B, building 9, Wanke Yuncheng phase III, Liuxin 4th Road, Xili community, Xili street, Nanshan District, Shenzhen (room 3101, block B, building 7, international innovation Valley)
Zhongshui Zhiyuan Assets Appraisal Co., Ltd. – 7-
Legal representative: Wu Xian
Registered capital: 226573529 yuan
Company type: joint stock limited company (listed, natural person investment or holding)
Date of establishment: December 28, 2001
Business term: long term
Business scope: general business items are: Technological Development of new engineering plastics, high-performance composites, carbon material composites (including carbon fiber, carbon nanotube, graphene or other carbon materials), aramid composites, special fiber materials, resin matrix composites, environmental protection materials and other related materials and China Trade (excluding franchised, specially controlled and franchised commodities); Equipment leasing (mechanical equipment leasing without operators, excluding financial leasing activities); Economic information consultation (excluding restricted items); Operate import and export business (except for projects prohibited by laws, administrative regulations and decisions of the State Council, and restricted projects can be operated only after obtaining permission); Own property lease. The licensed business items are: processing and production of new engineering plastics, high-performance composites, carbon material composites (including carbon fiber, carbon nanotube, graphene or other carbon materials), aramid composites, special fiber materials, resin matrix composites, environmental protection materials and other related materials.
(II) overview of the appraised unit
1. Basic information of the enterprise
Company name: Shenzhen Huabao biomaterial Technology Co., Ltd. (hereinafter referred to as Huabao biomaterial)
Unified social credit Code: 91440300ma5fwbw67a
Address: 17e, building 36, building 36-39, Qianhai garden, No. 288 Taoyuan Road, Qianhai community, Nantou street, Nanshan District, Shenzhen
Legal representative: Ni Zhuo
Registered capital: 1 million yuan
Zhongshui Zhiyuan Assets Appraisal Co., Ltd. – 8-
Company type: limited liability company (sole proprietorship of natural person)
Date of establishment: October 23, 2019
Business term: October 23, 2019 to no fixed term
Business scope: general business items are: research and development of biomaterials, functional materials and composite materials and their technical services; China Trade (excluding exclusive, exclusive and controlled commodities); Operate import and export business (except for items prohibited by laws, administrative regulations and decisions of the State Council, and restricted items can be operated only after obtaining permission).
2. Equity structure and capital contribution of the appraised unit on the base date
The equity structure and capital contribution on the benchmark date are as follows:
Monetary unit: RMB 10000
No. subscribed capital contribution of shareholders subscribed proportion paid in capital contribution paid in proportion
（%） （%）
1 Ni Zhuo 100.00 100.00% 1.00 1.00%
Total 100.00 100.00% 1.00 1.00%
3. Historical evolution of the appraised unit
Huabao biology was established on October 23, 2019 with a registered capital of 1 million yuan. When it was established, the equity structure was as follows:
